US Biomarker Market: Is the Rise of Liquid Biopsies Redefining Cancer Care in America?
The United States represents one of the most technologically advanced regions for diagnostic innovation, with a heavy emphasis on oncology and rare diseases. Within the US Biomarker Market, the move toward liquid biopsy—tracking circulating tumor DNA in the blood—is becoming a cornerstone of modern cancer management. This allows American clinicians to monitor tumor mutations in...
0 Comments 0 Shares 51 Views 0 Reviews
JogaJog https://jogajog.com.bd